Given the unique behavior of IL-8 in RCC TME51 and the usually poor correlation between circulating and tissue cytokine levels, investigating the source of IL-8 within RCC TME could offer further valuable insights (as also suggested by Yuen et al.29), potentially enhancing our understanding of tumor progression and therapeutic responses. This evidence concerns the gene CXCL8 and neoplasm.